News

Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Bugs, beets and other replacements for artificial food dyes
As food companies face pressure to eliminate artificial dyes, experts weigh in on the natural alternatives that could replace ...
FDA to undo some layoffs, after cuts to inspections and drug safety
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
How bugs and beet juice could play roles in the race to replace artificial dyes in food
Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...
US Justice Department unit for drug and food safety cases being disbanded
A Justice Department unit that handles criminal and civil enforcement of U.S. food and drug safety laws is being disbanded as ...
American Council on Science and Health2hOpinion
FDA in Crisis: How Trump Administration Downsizing Is Slowing Medical Innovation and Endangering Public Health
Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system.
Pa. regulators confident in state testing after Trump suspends dairy, poultry food safety programs
Officials from the Pennsylvania Department of Agriculture say that the state's food safety inspection system will be ...
Washingtonian on MSN1h
“Absolute Despair”: An NIH Worker on Job and Budget Cuts, RFK Jr, and Trump’s First 100 Days
How have the wild initial months of Donald Trump’s return to the White House landed on Washington? We asked the people who ...
Trump administration to announce plan to remove artificial food dyes from US food supply
The Trump administration plans to eliminate artificial food dyes linked to health risks from the U.S. food supply ...
FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24
IRVINE, CA / ACCESS Newswire / May 1, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, ...